Jonathan Patrick Riley

Title: The Innovations of Jonathan Patrick Riley

Introduction

Jonathan Patrick Riley is an accomplished inventor based in Williamsville, NY (US). He has made significant contributions to the field of gene therapy, particularly through his innovative work with adeno-associated viruses. His research focuses on the therapeutic potential of these viruses in treating various neurological conditions.

Latest Patents

Jonathan holds a patent for the "Injection of single-stranded or self-complementary adeno-associated virus 9 into the cerebrospinal fluid." This patent discloses that ssAAV and scAAV vectors of the same serotype, when administered via injection into the cerebrospinal fluid (CSF), exhibit different cellular tropisms in the central nervous system. This discovery allows for targeted treatment by using ssAAV or scAAV vectors encoding therapeutic proteins. Notably, scAAV9 can achieve superior transduction in critical brain areas, such as the hippocampus and cerebellum, while ssAAV9 minimizes transduction of astrocytes. In some cases, an immunosuppressive agent is also administered to enhance treatment efficacy.

Career Highlights

Throughout his career, Jonathan has worked with notable organizations, including Regenxbio Inc. and Emory University. His experience in these institutions has allowed him to advance his research and contribute to the development of innovative therapies.

Collaborations

Jonathan has collaborated with esteemed colleagues, including Nicholas M. Boulis and Karen Kozarsky. These partnerships have further enriched his research and expanded the impact of his work in the field of gene therapy.

Conclusion

Jonathan Patrick Riley's contributions to the field of gene therapy through his innovative patent and collaborations highlight his commitment to advancing medical science. His work continues to pave the way for new therapeutic approaches in treating neurological disorders.